REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD
2/1/2012 8:40:05 AM
More...
|
REGiMMUNE Presents New ToleroVax Data at the 2010 American Transplant Congress
5/5/2010 11:19:23 AM
More...
|
REGiMMUNE to Present Data From Preclinical Study of RGI-2001 at the 2010 American Transplant Congress
4/28/2010 11:26:50 AM
More...
|
Astellas Pharma Inc. and REGiMMUNE to Collaborate on New Vaccine Technology
7/22/2009 10:34:51 AM
More...
|
REGiMMUNE Presents Enhanced Efficacy Data in Preclinical Transplantation Models at the 2009 American Transplant Congress
6/1/2009 11:12:47 AM
More...
|
REGiMMUNE to Present at the 2009 American Transplant Congress
5/12/2009 11:36:38 AM
More...
|
REGiMMUNE Receives $12 Million in Grants to Develop Transplant and Allergy Drugs
12/8/2008 11:59:24 AM
More...
|
REGiMMUNE Raises $8,000,000 in Series B Financing
5/6/2008 6:56:39 AM
More...
|
REGiMMUNE Receives Grant Award From METI
8/8/2007 9:22:46 AM
More...
|
REGiMMUNE Announces Series B Financing
2/21/2007 9:47:10 AM
More...
|